Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
World Neurosurgery|October 7, 2018
Significance and Prognostic Value of The Coagulation Profile in Patients with Glioblastoma: Implications for Personalized TherapyStefania Elena Navone, Laura Guarnaccia, Marco Locatelli, et al.
Cancers|January 11, 2022
Frontiers in Anti-Cancer Drug Discovery: Challenges and Perspectives of Metformin as Anti-Angiogenic Add-On Therapy in GlioblastomaLaura Guarnaccia, Giovanni Marfia, Matteo Maria Masseroli, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 25, 2025
Revealing erythropoietin variant EV-3 as novel driving force and immunotherapeutic target in human glioblastomaStefania Elena Navone, Giovanni Marfia, Laura Guarnaccia, et al.
Scientific Reports|June 10, 2018
Angiogenesis in human brain tumors: screening of drug response through a patient-specific cell platform for personalized therapyLaura Guarnaccia, Stefania Elena Navone, Elena Trombetta, et al.
Stem Cells International|April 16, 2019
The Genetic Landscape of Human Glioblastoma and Matched Primary Cancer Stem Cells Reveals Intratumour Similarity and Intertumour HeterogeneityChiara Pesenti, Stefania Elena Navone, Laura Guarnaccia, et al.
EMBO Molecular Medicine|November 15, 2020
Decreased serum level of sphingosine-1-phosphate: a novel predictor of clinical severity in COVID-19Giovanni Marfia, Stefania Navone, Laura Guarnaccia, et al.
International Journal of Molecular Sciences|May 27, 2026
Correction: Navone et al. Role of Luteolin as Potential New Therapeutic Option for Patients with Glioblastoma Through Regulation of Sphingolipid Rheostat. Int. J. Mol. Sci. 2024, 25, 130Stefania Elena Navone, Laura Guarnaccia, Massimiliano D Rizzaro, et al.
International Journal of Molecular Sciences|January 11, 2024
Role of Luteolin as Potential New Therapeutic Option for Patients with Glioblastoma through Regulation of Sphingolipid RheostatStefania Elena Navone, Laura Guarnaccia, Massimiliano D Rizzaro, et al.
Pageof 3